0.6682
price up icon1.24%   0.0082
pre-market  Pre-mercato:  .68   0.0118   +1.77%
loading
Precedente Chiudi:
$0.66
Aprire:
$0.65
Volume 24 ore:
133.83K
Relative Volume:
0.25
Capitalizzazione di mercato:
$28.04M
Reddito:
$3.26M
Utile/perdita netta:
$-19.52M
Rapporto P/E:
-1.6705
EPS:
-0.4
Flusso di cassa netto:
$-24.10M
1 W Prestazione:
-1.47%
1M Prestazione:
+6.05%
6M Prestazione:
-28.84%
1 anno Prestazione:
-47.39%
Intervallo 1D:
Value
$0.65
$0.67
Intervallo di 1 settimana:
Value
$0.65
$0.7197
Portata 52W:
Value
$0.565
$1.49

Scynexis Inc Stock (SCYX) Company Profile

Name
Nome
Scynexis Inc
Name
Telefono
201-884-5485
Name
Indirizzo
1 EVERTRUST PLAZA, JERSEY CITY, NJ
Name
Dipendente
29
Name
Cinguettio
@scynexis
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
SCYX's Discussions on Twitter

Confronta SCYX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
SCYX
Scynexis Inc
0.6682 27.70M 3.26M -19.52M -24.10M -0.40
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
120.41 54.02B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.28 45.21B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.53 42.35B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
28.41 31.93B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
485.21 20.71B 3.08B 1.24B 1.07B 25.61

Scynexis Inc Stock (SCYX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-01-22 Iniziato Guggenheim Buy
2021-01-06 Iniziato Cantor Fitzgerald Overweight
2018-07-11 Aggiornamento Needham Hold → Buy
2018-06-27 Iniziato Maxim Group Buy
2017-10-24 Iniziato Guggenheim Buy
2017-07-10 Iniziato ROTH Capital Buy
2017-05-09 Downgrade Needham Buy → Hold
2017-03-03 Reiterato RBC Capital Mkts Outperform
2016-10-20 Iniziato H.C. Wainwright Buy
2016-10-07 Aggiornamento WBB Securities Buy → Strong Buy
2016-10-03 Ripresa Brean Capital Buy
2016-08-17 Iniziato Guggenheim Buy
2016-08-09 Reiterato Needham Buy
2016-08-09 Aggiornamento WBB Securities Speculative Buy → Buy
2016-03-28 Iniziato Brean Capital Buy
2015-12-29 Iniziato WBB Securities Speculative Buy
2015-11-16 Reiterato RBC Capital Mkts Outperform
2015-06-10 Iniziato Needham Buy
2014-05-29 Iniziato Canaccord Genuity Buy
2014-05-29 Iniziato RBC Capital Mkts Outperform
Mostra tutto

Scynexis Inc Borsa (SCYX) Ultime notizie

pulisher
02:43 AM

Why SCYNEXIS Inc. (135A) stock stays resilientWeekly Stock Report & Smart Swing Trading Techniques - Newser

02:43 AM
pulisher
Dec 04, 2025

How SCYNEXIS Inc. stock trades before earnings2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

SCYNEXIS (NASDAQ:SCYX) Stock Price Crosses Below 200-Day Moving Average – Should You Sell? - Defense World

Dec 04, 2025
pulisher
Dec 03, 2025

What is the fair value of SCYNEXIS Inc. stock nowEarnings Performance Report & Free Low Drawdown Momentum Trade Ideas - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Is SCYNEXIS Inc. (135A) stock considered safe havenDollar Strength & Low Risk Investment Opportunities - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Can SCYNEXIS Inc. stock surprise with earnings upsideJuly 2025 Reactions & Accurate Buy Signal Alerts - Newser

Dec 03, 2025
pulisher
Nov 30, 2025

Free cash flow per share of SCYNEXIS, Inc. – LSE:0L49 - TradingView

Nov 30, 2025
pulisher
Nov 30, 2025

Working capital per share of SCYNEXIS, Inc. – LSE:0L49 - TradingView

Nov 30, 2025
pulisher
Nov 29, 2025

Macro Review: Why SCYNEXIS Inc. stock is trending among retail tradersJuly 2025 Retail & Risk Adjusted Buy and Sell Alerts - BỘ NỘI VỤ

Nov 29, 2025
pulisher
Nov 28, 2025

Why SCYNEXIS Inc. stock is a must watch in 2025Portfolio Gains Report & Community Verified Swing Trade Signals - moha.gov.vn

Nov 28, 2025
pulisher
Nov 28, 2025

Why SCYNEXIS Inc. (135A) stock is listed among top recommendationsQuarterly Portfolio Review & Risk Managed Investment Entry Signals - BỘ NỘI VỤ

Nov 28, 2025
pulisher
Nov 27, 2025

Is SCYNEXIS Inc a good long term investmentGrowth Stock Opportunities & Exceptional Return Growth - earlytimes.in

Nov 27, 2025
pulisher
Nov 26, 2025

Is SCYNEXIS Inc. stock trading at a premium valuation2025 Short Interest & Stepwise Entry and Exit Trade Signals - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 25, 2025

It is Poised to be a Bull Market for Scynexis Inc (SCYX) - Setenews

Nov 25, 2025
pulisher
Nov 25, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Nov 25, 2025
pulisher
Nov 20, 2025

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Nov 20, 2025
pulisher
Nov 20, 2025

Investors in cash trouble should check out Scynexis Inc (SCYX) - Setenews

Nov 20, 2025
pulisher
Nov 20, 2025

Will SCYNEXIS Inc. (135A) stock outperform foreign stocksJuly 2025 Action & Risk Managed Trade Strategies - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Scynexis announces grant for Hackensack Meridian, Johns Hopkins collaboration - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

Analyzing recovery setups for SCYNEXIS Inc. investorsFed Meeting & Fast Gain Stock Trading Tips - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will SCYNEXIS Inc. stock recover faster than peersJuly 2025 Update & Technical Pattern Alert System - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Scynexis Transfers Brexafemme New Drug Application to GSK - MarketScreener

Nov 19, 2025
pulisher
Nov 19, 2025

SCYNEXIS, Inc. Completes Transfer of Brexafungerp New Drug Application to Gsk - MarketScreener

Nov 19, 2025
pulisher
Nov 19, 2025

Scynexis completes transfer of Brexafemme new drug application to GSK - MarketScreener

Nov 19, 2025
pulisher
Nov 19, 2025

SCYNEXIS Completes BREXAFEMME NDA Transfer to GSK, Positioning for Future Milestones and Royalties - Quiver Quantitative

Nov 19, 2025
pulisher
Nov 19, 2025

SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK - The Manila Times

Nov 19, 2025
pulisher
Nov 19, 2025

Scynexis completes transfer of Brexafemme New Drug Application To GSK - TradingView

Nov 19, 2025
pulisher
Nov 19, 2025

SCYNEXIS (NASDAQ: SCYX) transfers BREXAFEMME NDA to GSK, up to $145.5M - Stock Titan

Nov 19, 2025
pulisher
Nov 19, 2025

Is SCYNEXIS Inc. stock attractive for passive investorsMarket Sentiment Report & Long-Term Safe Investment Plans - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

How to build a dashboard for SCYNEXIS Inc. stockEarnings Overview Report & Risk Controlled Daily Trade Plans - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Scynexis fungerps among funding recipients - BioWorld MedTech

Nov 18, 2025
pulisher
Nov 17, 2025

SCYNEXIS receives $7 million annual grant for antifungal research By Investing.com - Investing.com Nigeria

Nov 17, 2025
pulisher
Nov 17, 2025

SCYX Secures Federal Grant for Antifungal Research - GuruFocus

Nov 17, 2025
pulisher
Nov 17, 2025

Scynexis Announces Federal Funding of Collaboration Between Hackensack Meridian CDI and Johns Hopkins Researchers to Develop New Therapeutics, Including Novel Fungerps, for Resistant Fungal Infections - The Manila Times

Nov 17, 2025
pulisher
Nov 17, 2025

SCYNEXIS Receives $35 Million NIH Grant to Develop Next-Generation Antifungal Therapies - Quiver Quantitative

Nov 17, 2025
pulisher
Nov 17, 2025

Scynexis (NASDAQ: SCYX) fungerps program included in $7M NIH CETR grant - Stock Titan

Nov 17, 2025
pulisher
Nov 16, 2025

Why SCYNEXIS Inc. (135A) stock benefits from AI revolutionForecast Cut & AI Forecast Swing Trade Picks - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Live market analysis of SCYNEXIS Inc.July 2025 Recap & Community Verified Trade Signals - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Will SCYNEXIS Inc. (135A) stock deliver stable dividendsJuly 2025 Closing Moves & Weekly Top Gainers Alerts - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

How geopolitical tensions affect SCYNEXIS Inc. stockEarnings Recap Summary & Consistent Return Investment Signals - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

SCYX | SCYNEXIS Inc. SEC Filings - MarketWatch

Nov 14, 2025

Scynexis Inc Azioni (SCYX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$40.02
price up icon 7.96%
$21.99
price down icon 0.86%
drug_manufacturers_specialty_generic RDY
$14.14
price up icon 0.07%
$10.72
price down icon 1.06%
$153.75
price up icon 1.18%
$485.21
price up icon 0.88%
Capitalizzazione:     |  Volume (24 ore):